AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Novel compound discovered has multiple potential indications.(immunostimulatory peptide derG)(Brief Article)
2002 MAY 22 - (NewsRx.com & NewsRx.net) -- CEL-SCI Corp. (CVM) announced the discovery of a novel compound called derG. The peptide is a modified, more potent version of a human sequence known to bind to both human and mouse immune cells and as such, the results obtained with it in mice are anticipated to have direct applicability in man. This peptide was discovered as an outgrowth of the company's ongoing research and development activities and collaborations with its L.E.A.P.S. technology.
In initial studies in mice, the compound appears to have potent immunostimulatory and vaccine adjuvant activities.
Potential indications for derG are:
* Infectious diseases - with antibiotic resistance on the rise, there is a great need for new treatments, particularly in hospital settings. derG could also potentially replace or augment current therapies for influenza, hepatitis B, and hepatitis C
* Sepsis
* Cancers
* Allergies - derG could be a more ...
- AEterna subsidiary Zentaris and Solvay Pharmaceuticals Sign Extensive...
- Press release article from: PR Newswire January 23, 2004 700+ words
...weight and orally-bioavailable peptidomimetic LHRH (Luteinizing Hormone Releasing Hormone) antagonists. Potential indications include endometriosis, uterus myoma, benign prostatic hyperplasia (BPH), as well as malignant disorders...
- Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the...
- Press release article from: PR Newswire July 1, 2008 700+ words
...its second major deal with Sciele Pharma, this time to co-develop a new compound for hypertension and other potential indications. Adrenalin is well known as the hormone that triggers the "fight or flight" reaction in response stress or...
- Novel compound deters drinking in mice.(Alcoholism)(L-152,804 found to block...
- Magazine article from: USA Today (Magazine) February 1, 2004 700+ words
...can curb mice's alcohol intake by treating them with a novel compound known as L-152,804. Whether the substance will be effective...blood-brain barrier," Hodge explains. "However, this novel compound has been shown both to cross the blood-brain barrier and...
- Promedior Initiates Phase 1 Clinical Trial of PRM-151, a Novel Compound for the...
- Newspaper article from: Clinical Trials Week August 3, 2009 700+ words
...initiation of a Phase 1 clinical trial of PRM-151, a novel compound in development for the treatment of fibrotic diseases and...disease settings, and are very excited to advance this novel compound into clinical research." About Promedior, Inc. Promedior...
- Publication No. WO/2009/128583 Published on Oct. 22, Assigned to Industry...
- News wire article from: US Fed News Service, Including US State News October 31, 2009 700+ words
...and Ha-Won Kim, both of South Korea, have developed a novel compound for enhancing ucp expression. The patent has been assigned...Property Organization: "The present invention relates to a novel compound, Juniperanol and compositions for preventing or treating...
- Patent No. 7,563,811 Issued on July 21, Assigned to Eisai R&D Management...
- News wire article from: US Fed News Service, Including US State News July 23, 2009 700+ words
...Great Britain, have developed a method for manufacturing of novel compound. The inventors were issued U.S. Patent No. 7,563...Trademark Office: "The present invention relates to a novel compound, a salt thereof and hydrates thereof, and to a method...
- Novel compound inhibits paclitaxel- and docetaxel-resistant tumor cell lines.
- Newspaper article from: Drug Week August 1, 2003 700+ words
...ovarian cancers, but many tumor types eventually become resistant to the drugs. In this study, researchers examined a novel compound in the same class, MAC-321, which inhibits the growth of paclitaxel- and docetaxel-resistant tumor cell lines grown...
- Novel compound may have advantages over nucleosides. (BI-RG-587, a new HIV...
- Newspaper article from: AIDS Alert June 1, 1991 700+ words
Novel compound may have advantages over nucleosides Laboratory studies suggest that a novel HIV reverse transcriptase inhibitor could be as effective...
